Cargando…

Proteomic profiling identifies markers for inflammation-related tumor–fibroblast interaction

BACKGROUND: Cancer associated fibroblasts are activated in the tumor microenvironment and contribute to tumor progression, angiogenesis, extracellular matrix remodeling, and inflammation. METHODS: To identify proteins characteristic for fibroblasts in colorectal cancer we used liquid chromatography-...

Descripción completa

Detalles Bibliográficos
Autores principales: Drev, Daniel, Bileck, Andrea, Erdem, Zeynep N., Mohr, Thomas, Timelthaler, Gerald, Beer, Andrea, Gerner, Christopher, Marian, Brigitte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689177/
https://www.ncbi.nlm.nih.gov/pubmed/29176937
http://dx.doi.org/10.1186/s12014-017-9168-7
_version_ 1783279325824417792
author Drev, Daniel
Bileck, Andrea
Erdem, Zeynep N.
Mohr, Thomas
Timelthaler, Gerald
Beer, Andrea
Gerner, Christopher
Marian, Brigitte
author_facet Drev, Daniel
Bileck, Andrea
Erdem, Zeynep N.
Mohr, Thomas
Timelthaler, Gerald
Beer, Andrea
Gerner, Christopher
Marian, Brigitte
author_sort Drev, Daniel
collection PubMed
description BACKGROUND: Cancer associated fibroblasts are activated in the tumor microenvironment and contribute to tumor progression, angiogenesis, extracellular matrix remodeling, and inflammation. METHODS: To identify proteins characteristic for fibroblasts in colorectal cancer we used liquid chromatography-tandem mass spectrometry to derive protein abundance from whole-tissue homogenates of human colorectal cancer/normal mucosa pairs. Alterations of protein levels were determined by two-sided t test with greater than threefold difference and an FDR of < 0.05. Public available datasets were used to predict proteins of stromal origin and link protein with mRNA regulation. Immunohistochemistry confirmed the localization of selected proteins. RESULTS: We identified a set of 24 proteins associated with inflammation, matrix organization, TGFβ receptor signaling and angiogenesis mainly originating from the stroma. Most prominent were increased abundance of SerpinB5 in the parenchyme and latent transforming growth factor β-binding protein, thrombospondin-B2, and secreted protein acidic-and-cysteine-rich in the stroma. Extracellular matrix remodeling involved collagens type VIII, XII, XIV, and VI as well as lysyl-oxidase-2. In silico analysis of mRNA levels demonstrated altered expression in the tumor and the adjacent normal tissue as compared to mucosa of healthy individuals indicating that inflammatory activation affected the surrounding tissue. Immunohistochemistry of 26 tumor specimen confirmed upregulation of SerpinB5, thrombospondin B2 and secreted protein acidic-and-cysteine-rich. CONCLUSIONS: This study demonstrates the feasibility of detecting tumor- and compartment-specific protein-signatures that are functionally meaningful by proteomic profiling of whole-tissue extracts together with mining of RNA expression datasets. The results provide the basis for further exploration of inflammation-related stromal markers in larger patient cohorts and experimental models. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12014-017-9168-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5689177
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-56891772017-11-24 Proteomic profiling identifies markers for inflammation-related tumor–fibroblast interaction Drev, Daniel Bileck, Andrea Erdem, Zeynep N. Mohr, Thomas Timelthaler, Gerald Beer, Andrea Gerner, Christopher Marian, Brigitte Clin Proteomics Research BACKGROUND: Cancer associated fibroblasts are activated in the tumor microenvironment and contribute to tumor progression, angiogenesis, extracellular matrix remodeling, and inflammation. METHODS: To identify proteins characteristic for fibroblasts in colorectal cancer we used liquid chromatography-tandem mass spectrometry to derive protein abundance from whole-tissue homogenates of human colorectal cancer/normal mucosa pairs. Alterations of protein levels were determined by two-sided t test with greater than threefold difference and an FDR of < 0.05. Public available datasets were used to predict proteins of stromal origin and link protein with mRNA regulation. Immunohistochemistry confirmed the localization of selected proteins. RESULTS: We identified a set of 24 proteins associated with inflammation, matrix organization, TGFβ receptor signaling and angiogenesis mainly originating from the stroma. Most prominent were increased abundance of SerpinB5 in the parenchyme and latent transforming growth factor β-binding protein, thrombospondin-B2, and secreted protein acidic-and-cysteine-rich in the stroma. Extracellular matrix remodeling involved collagens type VIII, XII, XIV, and VI as well as lysyl-oxidase-2. In silico analysis of mRNA levels demonstrated altered expression in the tumor and the adjacent normal tissue as compared to mucosa of healthy individuals indicating that inflammatory activation affected the surrounding tissue. Immunohistochemistry of 26 tumor specimen confirmed upregulation of SerpinB5, thrombospondin B2 and secreted protein acidic-and-cysteine-rich. CONCLUSIONS: This study demonstrates the feasibility of detecting tumor- and compartment-specific protein-signatures that are functionally meaningful by proteomic profiling of whole-tissue extracts together with mining of RNA expression datasets. The results provide the basis for further exploration of inflammation-related stromal markers in larger patient cohorts and experimental models. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12014-017-9168-7) contains supplementary material, which is available to authorized users. BioMed Central 2017-10-06 /pmc/articles/PMC5689177/ /pubmed/29176937 http://dx.doi.org/10.1186/s12014-017-9168-7 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Drev, Daniel
Bileck, Andrea
Erdem, Zeynep N.
Mohr, Thomas
Timelthaler, Gerald
Beer, Andrea
Gerner, Christopher
Marian, Brigitte
Proteomic profiling identifies markers for inflammation-related tumor–fibroblast interaction
title Proteomic profiling identifies markers for inflammation-related tumor–fibroblast interaction
title_full Proteomic profiling identifies markers for inflammation-related tumor–fibroblast interaction
title_fullStr Proteomic profiling identifies markers for inflammation-related tumor–fibroblast interaction
title_full_unstemmed Proteomic profiling identifies markers for inflammation-related tumor–fibroblast interaction
title_short Proteomic profiling identifies markers for inflammation-related tumor–fibroblast interaction
title_sort proteomic profiling identifies markers for inflammation-related tumor–fibroblast interaction
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689177/
https://www.ncbi.nlm.nih.gov/pubmed/29176937
http://dx.doi.org/10.1186/s12014-017-9168-7
work_keys_str_mv AT drevdaniel proteomicprofilingidentifiesmarkersforinflammationrelatedtumorfibroblastinteraction
AT bileckandrea proteomicprofilingidentifiesmarkersforinflammationrelatedtumorfibroblastinteraction
AT erdemzeynepn proteomicprofilingidentifiesmarkersforinflammationrelatedtumorfibroblastinteraction
AT mohrthomas proteomicprofilingidentifiesmarkersforinflammationrelatedtumorfibroblastinteraction
AT timelthalergerald proteomicprofilingidentifiesmarkersforinflammationrelatedtumorfibroblastinteraction
AT beerandrea proteomicprofilingidentifiesmarkersforinflammationrelatedtumorfibroblastinteraction
AT gernerchristopher proteomicprofilingidentifiesmarkersforinflammationrelatedtumorfibroblastinteraction
AT marianbrigitte proteomicprofilingidentifiesmarkersforinflammationrelatedtumorfibroblastinteraction